Bridging the diagnostic gap: coronary calcium and osteoporosis.

IF 2.9 Q3 ENDOCRINOLOGY & METABOLISM
Suvasini Lakshmanan, Matthew Budoff
{"title":"Bridging the diagnostic gap: coronary calcium and osteoporosis.","authors":"Suvasini Lakshmanan, Matthew Budoff","doi":"10.1080/17446651.2026.2635525","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Subclinical atherosclerosis measured by coronary artery calcium (CAC) and osteoporosis often co-exist as indolent 'silent' conditions, remain underdiagnosed and undertreated, and are associated with significant morbidity and mortality. Bone density can be obtained accurately from non-contrast CAC scans, allowing for 'opportunistic' screening of OP without the need for additional tests or radiation, and thereby enhancing the yield of CAC scans and improving patient care globally.</p><p><strong>Areas covered: </strong>This review will seek to highlight the significant relationship between osteoporosis and sub- clinical atherosclerosis. We also highlight the role of opportunistic measurements of bone mineral density (BMD) to accurately detect osteoporosis and osteopenia in CAC scans, without the need for additional radiation, tests, or financial burden.</p><p><strong>Expert opinion: </strong>Osteoporosis is a major health problem, associated with significant morbidity and mortality, yet the condition remains under recognized, under diagnosed and undertreated. CT measurement of bone density is likely superior to BMD measures by DEXA, for fracture prediction. A link between CAC and osteoporosis beyond aging alone highlights the potential role of 'opportunistic screening' by non-enhanced CAC scans for early detection of osteoporosis and subclinical atherosclerosis simultaneously.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":" ","pages":"1-7"},"PeriodicalIF":2.9000,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17446651.2026.2635525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Subclinical atherosclerosis measured by coronary artery calcium (CAC) and osteoporosis often co-exist as indolent 'silent' conditions, remain underdiagnosed and undertreated, and are associated with significant morbidity and mortality. Bone density can be obtained accurately from non-contrast CAC scans, allowing for 'opportunistic' screening of OP without the need for additional tests or radiation, and thereby enhancing the yield of CAC scans and improving patient care globally.

Areas covered: This review will seek to highlight the significant relationship between osteoporosis and sub- clinical atherosclerosis. We also highlight the role of opportunistic measurements of bone mineral density (BMD) to accurately detect osteoporosis and osteopenia in CAC scans, without the need for additional radiation, tests, or financial burden.

Expert opinion: Osteoporosis is a major health problem, associated with significant morbidity and mortality, yet the condition remains under recognized, under diagnosed and undertreated. CT measurement of bone density is likely superior to BMD measures by DEXA, for fracture prediction. A link between CAC and osteoporosis beyond aging alone highlights the potential role of 'opportunistic screening' by non-enhanced CAC scans for early detection of osteoporosis and subclinical atherosclerosis simultaneously.

弥合诊断差距:冠状动脉钙和骨质疏松症。
通过冠状动脉钙(CAC)测量的亚临床动脉粥样硬化和骨质疏松症通常作为惰性“沉默”状态共存,仍未得到充分诊断和治疗,并与显著的发病率和死亡率相关。通过非造影剂CAC扫描可以准确地获得骨密度,允许“机会性”筛查OP,而无需额外的检查或放疗,从而提高CAC扫描的产量,并改善全球患者护理。涵盖领域:这篇综述将试图强调骨质疏松症和亚临床动脉粥样硬化之间的重要关系。我们还强调了在CAC扫描中机会性测量骨密度(BMD)以准确检测骨质疏松症和骨质减少的作用,而不需要额外的放射、测试或经济负担。专家意见:骨质疏松症是一种主要的健康问题,与显著的发病率和死亡率相关,但这种疾病仍未得到充分认识、诊断和治疗。在骨折预测方面,CT测量骨密度可能优于DEXA测量骨密度。CAC与骨质疏松症之间的联系超越了单纯的衰老,强调了通过非增强CAC扫描“机会性筛查”同时发现骨质疏松症和亚临床动脉粥样硬化的潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Review of Endocrinology & Metabolism
Expert Review of Endocrinology & Metabolism ENDOCRINOLOGY & METABOLISM-
CiteScore
4.80
自引率
0.00%
发文量
44
期刊介绍: Implicated in a plethora of regulatory dysfunctions involving growth and development, metabolism, electrolyte balances and reproduction, endocrine disruption is one of the highest priority research topics in the world. As a result, we are now in a position to better detect, characterize and overcome the damage mediated by adverse interaction with the endocrine system. Expert Review of Endocrinology and Metabolism (ISSN 1744-6651), provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书